Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michelle M. Barnard"'
Autor:
Monica van Wijk, Michelle M. Barnard, Amanda Fernandez, Keith Cloete, Matodzi Mukosi, Richard D. Pitcher
Publikováno v:
South African Journal of Radiology, Vol 25, Iss 1, Pp e1-e7 (2021)
Background: Although global use of medical imaging has increased significantly, little is known about utilisation trends in low- and middle-income countries (LMICs). Objectives: To evaluate changes over a decade in public sector diagnostic imaging u
Externí odkaz:
https://doaj.org/article/c2ff473f44e448c9b6feb17ba70fe643
Autor:
Parak Y; Division of Radiodiagnosis, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.; Department of Radiodiagnosis, Tygerberg Hospital, Cape Town, South Africa., Davis R; Division of Radiodiagnosis, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.; Department of Radiodiagnosis, Tygerberg Hospital, Cape Town, South Africa., Barnard M; Sub-Directorate Medical Imaging Services, Directorate: Health Technology, Western Cape Government Health and Wellness, Cape Town, South Africa., Fernandez A; Sub-Directorate Medical Imaging Services, Directorate: Health Technology, Western Cape Government Health and Wellness, Cape Town, South Africa., Cloete K; Western Cape Government Health and Wellness, Cape Town, South Africa., Mukosi M; Tygerberg Hospital, Cape Town, South Africa., Pitcher RD; Division of Radiodiagnosis, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.; Department of Radiodiagnosis, Tygerberg Hospital, Cape Town, South Africa.
Publikováno v:
SA journal of radiology [SA J Radiol] 2022 Jul 22; Vol. 26 (1), pp. 2464. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Drug combination screening as a translational approach toward an improved drug therapy for chordoma.
Autor:
Scheipl S; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Barnard M; Cancer Research UK - AstraZeneca Antibody Alliance Laboratory, Cambridge, UK., Lohberger B; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria. birgit.lohberger@medunigraz.at., Zettl R; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Brcic I; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Liegl-Atzwanger B; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Rinner B; Division of Biomedical Research, Medical University of Graz, Graz, Austria., Meindl C; Center for Medical Research, Medical University of Graz, Graz, Austria., Fröhlich E; Center for Medical Research, Medical University of Graz, Graz, Austria.
Publikováno v:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2021 Dec; Vol. 44 (6), pp. 1231-1242. Date of Electronic Publication: 2021 Sep 22.
Autor:
Chan DTY; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Jenkinson L; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Haynes SW; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Austin M; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom., Diamandakis A; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Burschowsky D; Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Department of Molecular and Cell Biology, University of Leicester, LE1 7HB Leicester, United Kingdom., Seewooruthun C; Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Department of Molecular and Cell Biology, University of Leicester, LE1 7HB Leicester, United Kingdom., Addyman A; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Fiedler S; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Ryman S; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Whitehouse J; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Slater LH; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Gowans E; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Shibata Y; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Barnard M; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Wilkinson RW; Early Oncology Discovery, Oncology Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom., Vaughan TJ; Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom., Holt SV; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom., Cerundolo V; Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom., Carr MD; Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7HB Leicester, United Kingdom; mdc12@leicester.ac.uk maria.groves@astrazeneca.com.; Department of Molecular and Cell Biology, University of Leicester, LE1 7HB Leicester, United Kingdom., Groves MAT; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom; mdc12@leicester.ac.uk maria.groves@astrazeneca.com.; Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Jul 21; Vol. 117 (29), pp. 16949-16960. Date of Electronic Publication: 2020 Jul 02.
Autor:
Austin M; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Antibody Discovery & Protein Engineering, BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK., Burschowsky D; Leicester Institute of Structural and Chemical Biology and the Department of Molecular and Cell Biology, University of Leicester , Leicester, UK., Chan DTY; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Jenkinson L; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Haynes S; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Diamandakis A; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Seewooruthun C; Leicester Institute of Structural and Chemical Biology and the Department of Molecular and Cell Biology, University of Leicester , Leicester, UK., Addyman A; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Fiedler S; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Ryman S; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Whitehouse J; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Slater LH; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Hadjinicolaou AV; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford , Oxford, UK., Gileadi U; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford , Oxford, UK., Gowans E; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Shibata Y; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Barnard M; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Kaserer T; Cancer Research UK, Cancer Therapeutics Unit, The Institute of Cancer Research , London, UK., Sharma P; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Luheshi NM; Early Oncology Discovery, Oncology R&D, AstraZeneca , Cambridge, UK., Wilkinson RW; Early Oncology Discovery, Oncology R&D, AstraZeneca , Cambridge, UK., Vaughan TJ; Antibody Discovery & Protein Engineering, BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK., Holt SV; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK., Cerundolo V; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford , Oxford, UK., Carr MD; Leicester Institute of Structural and Chemical Biology and the Department of Molecular and Cell Biology, University of Leicester , Leicester, UK., Groves MAT; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Antibody Discovery & Protein Engineering, BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.
Publikováno v:
MAbs [MAbs] 2020 Jan-Dec; Vol. 12 (1), pp. 1801230.
Autor:
Scheipl S; University College London Cancer Institute, London, UK.; Department of Orthopaedics and Orthopaedic Surgery, Medical University of Graz, Austria., Barnard M; University College London Cancer Institute, London, UK.; Cancer Research Technology Discovery Laboratories, Cambridge, UK.; CRUK-MedImmune Alliance Laboratory, Cambridge, UK., Cottone L; University College London Cancer Institute, London, UK., Jorgensen M; University College London Cancer Institute, London, UK., Drewry DH; GlaxoSmithKline, Research Triangle Park, NC, USA.; SGC-UNC, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA., Zuercher WJ; GlaxoSmithKline, Research Triangle Park, NC, USA.; SGC-UNC, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA., Turlais F; Cancer Research Technology Discovery Laboratories, Cambridge, UK., Ye H; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK., Leite AP; University College London Cancer Institute, London, UK., Smith JA; Cancer Research Technology Discovery Laboratories, Cambridge, UK., Leithner A; Department of Orthopaedics and Orthopaedic Surgery, Medical University of Graz, Austria., Möller P; Institute of Pathology, Ulm University, Germany., Brüderlein S; Institute of Pathology, Ulm University, Germany., Guppy N; University College London Advanced Diagnostics, London, UK., Amary F; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK., Tirabosco R; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK., Strauss SJ; University College London Cancer Institute, London, UK., Pillay N; University College London Cancer Institute, London, UK.; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK., Flanagan AM; University College London Cancer Institute, London, UK.; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.; University College London Advanced Diagnostics, London, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2016 Jul; Vol. 239 (3), pp. 320-34. Date of Electronic Publication: 2016 May 31.